Original Antigenic Sin on Antibody Response in SARS-CoV-2 Infection

被引:0
|
作者
Wang, Miao [1 ]
Guo, Huimin [1 ]
Ju, Bin [1 ,2 ]
Zhang, Zheng [1 ,2 ,3 ]
机构
[1] Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Affiliated Hosp 2, Inst Hepatol,Sch Med ,Natl Clin Res Ctr Infect Dis, Shenzhen 518112, Guangdong Provi, Peoples R China
[2] Guangdong Key Lab Antiinfect Drug Qual Evaluat, Shenzhen 518112, Guangdong Provi, Peoples R China
[3] Chinese Acad Med Sci, Shenzhen Res Ctr Communicable Dis Diag & Treatment, Shenzhen 518112, Guangdong Provi, Peoples R China
来源
INFECTIOUS DISEASES & IMMUNITY | 2024年 / 4卷 / 03期
基金
中国国家自然科学基金;
关键词
SARS-CoV-2; Original antigenic sin; Antibody response; Omicron subvariants; Vaccine design; CELLS;
D O I
10.1097/ID9.0000000000000125
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Infection and vaccination can provide protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the emergence of SARS-CoV-2 variants has persisted, leading to breakthrough infections. Owing to the original antigenic sin (OAS), variant breakthrough infection or vaccination potentially induces a stronger antibody response against the ancestral strain than to subsequent variants, as in the case of influenza. Thus, overcoming OAS is important for the development of future vaccine designs. This review summarizes the recent findings on OAS in the antibody response to SARS-CoV-2 and its variants, with an emphasis on future vaccine designs.
引用
收藏
页码:132 / 137
页数:6
相关论文
共 50 条
  • [21] Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
    Marchi, Serena
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 309 - 309
  • [22] The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
    Liu, Chang
    Zhou, Daming
    Nutalai, Rungtiwa
    Duyvesteyn, Helen M. E.
    Tuekprakhon, Aekkachai
    Ginn, Helen M.
    Dejnirattisai, Wanwisa
    Supasa, Piyada
    Mentzer, Alexander J.
    Wang, Beibei
    Case, James Brett
    Zhao, Yuguang
    Skelly, Donal T.
    Chen, Rita E.
    Johnson, Sile Ann
    Ritter, Thomas G.
    Mason, Chris
    Malik, Tariq
    Temperton, Nigel
    Paterson, Neil G.
    Williams, Mark A.
    Hall, David R.
    Clare, Daniel K.
    Howe, Andrew
    Goulder, Philip J. R.
    Fry, Elizabeth E.
    Diamond, Michael S.
    Mongkolsapaya, Juthathip
    Ren, Jingshan
    Stuart, David, I
    Screaton, Gavin R.
    CELL HOST & MICROBE, 2022, 30 (01) : 53 - +
  • [23] Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS
    Fierz, Walter
    Walz, Brigitte
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [24] "Original antigenic sin": A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants
    Noori, Maryam
    Nejadghaderi, Seyed Aria
    Rezaei, Nima
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (08): : 1091 - 1092
  • [25] Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection, and change to single-dose vaccination
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (12) : 6474 - 6474
  • [26] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [27] Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies
    Evans, John P.
    Liu, Shan-Lu
    JOURNAL OF IMMUNOLOGY, 2023, 211 (10): : 1459 - 1467
  • [28] SARS-CoV-2 antibody response duration and neutralization following natural infection
    Dukes, Christopher W.
    Rossetti, Renata A. M.
    Hensel, Jonathan A.
    Snedal, Sebastian
    Cubitt, Christopher L.
    Schell, Michael J.
    Abrahamsen, Martha
    Isaacs-Soriano, Kimberly
    Kennedy, Kayoko
    Mangual, Leslie N.
    Whiting, Junmin
    Martinez-Brockhus, Veronica
    Islam, Jessica Y.
    Rathwell, Julie
    Beatty, Matthew
    Hall, Amy M.
    Abate-Daga, Daniel
    Giuliano, Anna R.
    Pilon-Thomas, Shari
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2023, 3 (03):
  • [29] Breadth and function of antibody response to acute SARS-CoV-2 infection in humans
    Huang, Kuan-Ying A.
    Tan, Tiong Kit
    Chen, Ting-Hua
    Huang, Chung-Guei
    Harvey, Ruth
    Hussain, Saira
    Chen, Cheng-Pin
    Harding, Adam
    Gilbert-Jaramillo, Javier
    Liu, Xu
    Knight, Michael
    Schimanski, Lisa
    Shih, Shin-Ru
    Lin, Yi-Chun
    Cheng, Chien-Yu
    Cheng, Shu-Hsing
    Huang, Yhu-Chering
    Lin, Tzou-Yien
    Jan, Jia-Tsrong
    Ma, Che
    James, William
    Daniels, Rodney S.
    McCauley, John W.
    Rijal, Pramila
    Townsend, Alain R.
    PLOS PATHOGENS, 2021, 17 (02)
  • [30] Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination
    Garcia, Laura
    Woudenberg, Tom
    Rosado, Jason
    Dyer, Adam H.
    Donnadieu, Francoise
    Planas, Delphine
    Bruel, Timothee
    Schwartz, Olivier
    Prazuck, Thierry
    Velay, Aurelie
    Fafi-Kremer, Samira
    Batten, Isabella
    Reddy, Conor
    Connolly, Emma
    McElheron, Matt
    Kennelly, Sean P.
    Bourke, Nollaig M.
    White, Michael T.
    Pelleau, Stephane
    VIRUSES-BASEL, 2022, 14 (07):